Effects of agomelatine on sleep electroencephalogram parameters compared to selective serotonin reuptake inhibitors in patients with major depressive disorder: a six-week randomised, double-blind parallel group study versus comparator, followed by a double-blind optional treatment extension period up to six months
Phase of Trial: Phase II
Latest Information Update: 17 Sep 2014
At a glance
- Drugs Agomelatine; Serotonin uptake inhibitors
- Indications Major depressive disorder
- Focus Pharmacodynamics
- 16 Jul 2007 New trial record.